Post-Injection Delirium/Sedation Syndrome after Olanzapine Long-Acting Intramuscular Injection - Who is at Risk?

Pharmacokinetics of olanzapine long-acting injection

(2014) Stephan Heres et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

LC–MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood

(2013) Danielle S. Fisher et al.   FORENSIC SCIENCE INTERNATIONAL

Olanzapine Postinjection Delirium/Sedation Syndrome: An Unrecognized Diagnosis in the Emergency Department

(2013) Dominique Vodovar et al.   JOURNAL OF EMERGENCY MEDICINE

A review of olanzapine pamoate

(2012) Pierre Chue et al.   EXPERT OPINION ON PHARMACOTHERAPY

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases

(2010) Holland C Detke et al.   BMC Psychiatry

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

(2010) David P McDonnell et al.   BMC Psychiatry

Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia

(2009) John M. Kane et al.   AMERICAN JOURNAL OF PSYCHIATRY